Safety of fruquintinib in young and late-elderly Chinese patients with colorectal cancer in real-world clinical practice: Age subgroup analysis of a fruquintinib phase IV study. This is an ASCO ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback